602 related articles for article (PubMed ID: 22339462)
1. Novel routes for allergen immunotherapy: safety, efficacy and mode of action.
Moingeon P; Mascarell L
Immunotherapy; 2012 Feb; 4(2):201-12. PubMed ID: 22339462
[TBL] [Abstract][Full Text] [Related]
2. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy for allergic respiratory diseases: efficacy and safety.
Passalacqua G; Canonica GW
Immunol Allergy Clin North Am; 2011 May; 31(2):265-77, ix. PubMed ID: 21530819
[TBL] [Abstract][Full Text] [Related]
4. Novel administration routes for allergen-specific immunotherapy: a review of intralymphatic and epicutaneous allergen-specific immunotherapy.
von Moos S; Kündig TM; Senti G
Immunol Allergy Clin North Am; 2011 May; 31(2):391-406, xi. PubMed ID: 21530827
[TBL] [Abstract][Full Text] [Related]
5. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
6. Current advances in house dust mite allergen immunotherapy (AIT): Routes of administration, biomarkers and molecular allergen profiling.
Batard T; Canonica WG; Pfaar O; Shamji MH; O'Hehir RE; van Zelm MC; Mascarell L
Mol Immunol; 2023 Mar; 155():124-134. PubMed ID: 36806944
[TBL] [Abstract][Full Text] [Related]
7. New routes of allergen immunotherapy.
Aricigil M; Muluk NB; Sakarya EU; Sakalar EG; Senturk M; Reisacher WR; Cingi C
Am J Rhinol Allergy; 2016 Nov; 30(6):193-197. PubMed ID: 28124639
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
9. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
Mascarell L; Van Overtvelt L; Moingeon P
Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
[TBL] [Abstract][Full Text] [Related]
10. Allergen immunotherapy: an updated review of safety.
James C; Bernstein DI
Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
[TBL] [Abstract][Full Text] [Related]
11. A comparison of immunotherapy delivery methods for allergen immunotherapy.
Klimek L; Pfaar O
Expert Rev Clin Immunol; 2013 May; 9(5):465-74; quiz 475. PubMed ID: 23634740
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.
Cox L; Calderón M; Pfaar O
Immunotherapy; 2012 Jun; 4(6):601-16. PubMed ID: 22788128
[TBL] [Abstract][Full Text] [Related]
13. Impact of allergen immunotherapy in allergic asthma.
Zhang W; Lin C; Sampath V; Nadeau K
Immunotherapy; 2018 Jun; 10(7):579-593. PubMed ID: 29569506
[TBL] [Abstract][Full Text] [Related]
14. Induction of allergen-specific tolerance via mucosal routes.
Mascarell L; Zimmer A; Van Overtvelt L; Tourdot S; Moingeon P
Curr Top Microbiol Immunol; 2011; 352():85-105. PubMed ID: 21562971
[TBL] [Abstract][Full Text] [Related]
15. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
16. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.
Moingeon P; Mascarell L
Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498
[TBL] [Abstract][Full Text] [Related]
17. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
[TBL] [Abstract][Full Text] [Related]
18. The history of sublingual immunotherapy.
Pajno GB; Barberi S
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
[TBL] [Abstract][Full Text] [Related]
19. Anaphylaxis: still a ghost behind allergen immunotherapy.
Makatsori M; Calderon MA
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):316-22. PubMed ID: 24873937
[TBL] [Abstract][Full Text] [Related]
20. Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral.
Frati F; Scurati S; Puccinelli P; Justicia JL; Adamec T; Sieber HJ; Ras L; David M; Marcucci F; Incorvaia C
Expert Opin Biol Ther; 2009 Sep; 9(9):1207-15. PubMed ID: 19601728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
